News

Q&A: Could a new drug help prevent heart attacks and strokes?
A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and ...
More people with type 1 diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
Science Daily20h
Students lead breakthrough study on diabetes drugs and dementia risk
Two undergraduate medicine students have led a major study examining how cardioprotective glucose-lowering therapies -- medications that lower blood sugar and reduce the risk of heart disease in ...
ALS drug effectively treats Alzheimer's disease in animal study
Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...
The American Journal of Managed Care1d
Guselkumab Shows Sustained Efficacy in Phase 3b APEX Study for Active PsA
Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the sustained efficacy of guselkumab (Tremfya; Johnson & Johnson) in limiting ...
Zenas: Differentiated B-Cell Targeting Drug With Q3 Of 2025 Catalyst
Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...
New Scientist2d
Drugs like Ozempic and Wegovy could significantly cut dementia risk
Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...